CDW Corp
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-05.
0001402057-26-000065
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-04.
0001402057-26-000114
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 13 previous paragraphs and 14 current paragraphs.
10 unchanged; 2 reworded; 2 added; 1 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
See “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our risk factors during the nine months ended September 30, 2026.
Added paragraphs (2)
Current report
On September 25, 2026, the Company issued equity awards consisting of 327,370 shares of restricted common stock, with a fair value of $44 million, as partial consideration for the acquisition of Lovelytics. For additional information regarding the acquisition and related consideration, see Note 3, (Acquisitions) to the accompanying condensed consolidated financial statements.
Current report
The shares were issued to former equity holders of Lovelytics who represented that they are accredited investors, as defined in Rule 501(a) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). The shares were issued in reliance upon an exemption from registration under the Securities Act pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D.
Removed paragraphs (1)
Reworded paragraphs (2)
Previous wording
See “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our risk factors during the six months ended June 30, 2026.
Current wording
See “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes to our risk factors during the nine months ended September 30, 2026.
Previous wording
On May 13, 2026, the Company announced that its Board of Directors authorized a $1 billion increase to the Company’s share repurchase program (which was incremental to the approximately $484 million that was remaining as of March 31, 2026 under the $750 million authorization announced on February 5, 2025) under which the Company may repurchase shares of its common stock from time to time in privately negotiated transactions, open market purchases, or other transactions as permitted by securities laws and other legal requirements. The timing and amounts of any purchases will be based on market conditions and other factors including but not limited to share price, regulatory requirements, and capital availability. The program does not require the purchase of any minimum dollar amount or number of shares, and the program may be modified, suspended, or discontinued at any time. As of June 30, 2026, the Company has approximately $1,138 million remaining under the program.
Current wording
On May 13, 2026, the Company announced that its Board of Directors authorized a $1 billion increase to the Company’s share repurchase program (which was incremental to the remaining amount under the $750 million authorization announced on February 5, 2025) under which the Company may repurchase shares of its common stock from time to time in privately negotiated transactions, open market purchases, or other transactions as permitted by securities laws and other legal requirements. The timing and amounts of any purchases will be based on market conditions and other factors including but not limited to share price, regulatory requirements, and capital availability. The program does not require the purchase of any minimum dollar amount or number of shares, and the program may be modified, suspended, or discontinued at any time. As of September 30, 2026, the Company has approximately $1,032 million remaining under the program.